Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page header/footer is updated to show a newer ClinicalTrials.gov site revision (v3.5.3 instead of v3.5.2), reflecting a platform release rather than a change to the underlying clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T05:46:44.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:17:46.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    - Revision tag updated from v3.4.3 to v3.5.0; no substantive updates to the study details are evident.
    Difference
    0.1%
    Check dated 2026-03-19T05:10:55.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no visible changes to study content or page functionality.
    Difference
    0.1%
    Check dated 2026-03-12T00:55:27.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Added site revision banner 'Revision: v3.4.2'; removed the previous revision banner 'Revision: v3.4.1' and the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T10:28:10.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    A government funding lapse notice with operating status links was added, and the site version was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:25:15.000Z thumbnail image

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.